CB 300919 [289715-28-2]

MedChem Express

CB 300919 [289715-28-2]

10

289715-28-2

Research Use Only

98.01%

C32H34ClN7O2

584.11

CB 300919 is a quinazoline-based antitumour agent with high activity in the CH1 human ovarian tumour xenograft. CB 300919 has a continuous exposure (96 h) growth inhibition IC50 value of 2 nM in human CH1 ovarian tumor xenograft.

CN1CCN(CC1)CC2=NC3=C(C(N2C)=O)C=C(CN(CC#C)C4=CC=C(C=C4)C(NCC5=CC=CN=C5)=O)C(Cl)=C3

2°C to 8°C,-20°C,-80°C

12352200